These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2599761)

  • 21. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu.
    Mills JS; Miettinen HM; Cummings D; Jesaitis AJ
    J Biol Chem; 2000 Dec; 275(50):39012-7. PubMed ID: 10960471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL
    Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
    Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformationally constrained chemotactic peptide analogs of high biological activity.
    Iqbal M; Balaram P; Showell HJ; Freer RJ; Becker EL
    FEBS Lett; 1984 Jan; 165(2):171-4. PubMed ID: 6692914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.
    Zecchini GP; Paradisi MP; Torrini I; Spisani S
    Arch Pharm (Weinheim); 1995 Sep; 328(9):673-6. PubMed ID: 7487425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
    Kermode JC; Muthukumaraswamy N; Freer RJ
    J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular dichroism conformational study of the chemotactic peptide formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Bakir M; Stevens ES
    Int J Pept Protein Res; 1982 Feb; 19(2):133-6. PubMed ID: 7118390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly active chemotactic peptide analog incorporating the unusual residue 1-aminocyclohexanecarboxylic acid at position 2.
    Sukumar M; Raj PA; Balaram P; Becker EL
    Biochem Biophys Res Commun; 1985 Apr; 128(1):339-44. PubMed ID: 3985973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic formyl-methionyl chemoattractants: a conformation-activity study of oxidized tripeptides.
    Toniolo C; Bonora GM; Freer RJ; Kennedy SP; Pittenger KL; Becker EL
    Peptides; 1988; 9(6):1195-205. PubMed ID: 3247246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2.
    Toniolo C; Crisma M; Valle G; Bonora GM; Polinelli S; Becker EL; Freer RJ; Sudhanand ; Rao RB; Balaram P
    Pept Res; 1989; 2(4):275-81. PubMed ID: 2520765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Mastropietro G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F; deBlois D; Laplante C; Petitclerc E; Pelletier G; Grose JH; Hugli TE
    Circ Res; 1990 Nov; 67(5):1059-70. PubMed ID: 1699682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.